Search Share Prices

AZN Headlines - Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment and Drugs Market Outlook, Size, Demand, Competitive Analysis, And Growth Factors

Hoffmann-La Roche Ltd (SWX: RO), Eli Lilly and Company (NYSE: LLY), Bristol-Myers Squibb Company (NYSE: BMY), AstraZeneca plc (LON: AZN), Merck Sharp & Dohme Corp. (Merck & Co., Inc.) (NYSE: MRK), ...

Read More »

NetScientific tops the risers after deal with AstraZeneca

NetScientific PLC's , up 235 at 92p, was the top riser after striking a licensing deal with AstraZeneca PLC . Its ProAxsis subsidiary is to work with AstraZeneca over the validati ...

Read More »

NetScientific's ProAxsis to validate and commercialise AstraZeneca's coronavirus vaccine assay

It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources ...

Read More »

Leerink Partners Stick to Their Buy Rating for Astrazeneca Plc

Leerink Partners analyst Andrew Berens maintained a Buy rating on Astrazeneca Plc (LON:AZN) on Friday, setting a price target of $64, which is approximately 13.78% above the present share price of $56 ...

Read More »

Dementia and Alzheimer's Disease Treatment Market Forecast With Trends, Challenges & Drivers and Key Players

Research Nester released a report titled "Dementia and Alzheimer's Disease Treatment Market: Global Demand Analysis ...

Read More »

Related Share Prices